NEW YORK — Fosun Pharmaceutical said on Thursday that its Fosun Long March Medical Science subsidiary has received emergency approval from China's National Medical Products Administration for a SARS-CoV-2 detection kit.
According to Shanghai, China-based Fosun Pharma, the kit is designed to detect the virus' ORF1ab, N, and E genes, and can proess 96 samples within two hours.
Earlier this month, Fosun Long March received CE marking for its SARS-CoV-2 nucleic acid detection kit, Fosun Pharma said.
Copyright © 2025 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.
Go back
